| abstract |
The present invention relates to 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a ] A crystalline form of pyrazine, which can be used as a stimulator of soluble guanylate cyclase (sGC). The present invention also provides pharmaceutically acceptable compositions comprising the crystalline forms, and methods of using the compositions to treat various disorders. |